Introduction
Granulocytic sarcoma is synonymous with extramedullary myeloid sarcoma, myeloblastoma, and chloroma.
These solid tumors are composed ofleukemic cells.They commonly prese nt in the soft tissues of the head and neck and in in tra cranial sites, although they may arise anywhere in th e bo dy. The diagnosis is ma de clinically on the basis of a combination of location , pathologic appeara nce,and a concurrent diagnosis of acute leukemia or myelodysplasticsyndrome.Granulocyticsarcoma may be seen in multiple clinical scenarios: as a pr ecur sor of acute myelogenous leukemia in nonleukemic pat ients, as a herald ofimpending blast crisisin chronicmyelogeno us leukemia, as a leukemic transformation of myelodysplastic disease, and as a distinct tissue manifestation in patients already diagnosed with acute myelogenous leukemia. ' Granulocytic sarcoma may also present in nonleukemic patients, who tend to have a better prognosis if diagnosed and treated promptly. ' Granulocytic sarcomas have been reported frequently in the orbits' and less frequen tly in various other sites, includin g the gingiva,"maxilla,' parotid gland."" temporal bon e,"temporal lobe of the brain," cerebellopontine angle (causing sudden sensorineural hearing 10ss),10 and masseter muscle.I I Wh ile there are reports of these tumors occurring in the nasal cavity" and paranasal sinuses," such cases are thought to be exceedingly rare .
We describe a new case of granulocyt ic sarcoma of the nasal cavity.
Case repo rt
A 55-year-old man was referred to our ENT clinic for evaluation of a left-sided nasal mass. He had originally presented to his primary care physician and reported a l -rnonth history of headaches and double vision that had become worse during the preceding 2 weeks. He also reported that his left eye had been swollen for the past mo nt h and that the edema ha d become more pronounced over the past few weeks. Findings on a review of systems were positive for occasiona l left-sided epistaxis and left-s ided nasal airway obstruction. The patient denied any decrease in visual acuity or weight loss. Otherwise, his medical history was significant for Philadelphia chromosome-positive chronic myelogenous leukemia, which had been treated with oral imatinib.
Physical examination revealed left-sided proptosis with periorbital edema and erythema and a left-sided crani al nerve VI palsy. Endoscopic examination of the nasal cavity detected a homogeneous, nonpulsatile, nonulcerated mass between the left middle turbinate and the nasal septum that appeared to be superiorly based. Computed tomography (CT) and magnetic resonance imaging (MRI) identified a soft-tissue mass that involved the entire left nasal cavity, the ethmoid and fronta l sinuses, and part of the right ethmoid cavity (figure I ). Bony erosio n of the anterior cribriform plate and left lamina papyracea was also noted on review of the films. ogenous leukemia, it may not be as easily reached in patients who lack any history of known hematologic abnorrnalities.t-P -" So again , it is imperative that clinicians maintain a high index of suspicion for this relatively rare entity because studies have shown that pat ients without a histo ry of leukemia may avoid progression to overt leukemia if isolated granulocytic sarcoma is trea ted appropriately with systemic chemotherapy." In additio n, a pro mpt diagnosis prior to any bo ne marrow ' involvement may help improve the cure rate."
Even when granulocytic sarcoma appears to beisolated, it is m ost likely a parti al m an ifestation of a systemic disease. There fore, some aut ho rs advoca te that patient s sho uld be treated with aggressivesystemicchemo therapy (i.e.,the acute nonlymph ocyticleukem ia protocol) to potentially pr event progression to systemic leukem ia.2.19.20 Surgery and radiation therapy do not appear to playa role in the treatment of granulocytic sarcoma except in cases of resid ual or symptomatic disease. 19, 21 An en doscopic surgical biopsy was performed in the operating room (figure 2). Patho logic ana lysis of th e spec ime n revealed that the mass was a high-grade malignant blastic neoplasm with myeloid, T-Iym ph oblastic, an d B-Iymphobl astic differentiat ion-that is, a gra nulocytic sar coma ( figure 3 ). Histologic examina tion of a sub sequ ent bon e m arrow biopsy confirm ed that th e patient had also experienced it relapse Fi gure 1. A: Noncontrast CT of the paranasalsinuses shows the left sinonasal niass. B: T2-weighted ofhis chronic myelogenous MRI shows the infiltration of the orbitwith contralateral extension.
leukemia. Rap id ini tiat ion' of chemotherapy pro du ced a substantial decrease in tu mor bulk.
Discussion
In additio n to gran ulocytic sarcoma, the differential diagnosis ofhernatolymphoid tumors of the nasal cavity includes non -H od gkin lym phoma, diffuse large B-cell lym ph oma, extramedullary plasma cyto ma , histiocytic sarco ma, and Langerh ans cell histiocytosis.14,15Maki ng th e correct diagnosis of these relatively rare tumo rs can be cha llenging , especially th ose that are poorly differentiated variants. 15 Granulocyticsarcom a isoften mistaken for lymphom a or other poorly differenti ated ma lignanc ies,and th e correct diagn osis requ ires a high ind ex of clinical suspicion. The clinician sho uld be aler ted to the possibility of th is diagn osis by a find ing of a less different iated neo plasm combined with pathologic evidence of myeloid differentiation in the presenceof positive testing for chloroace tate esterase, myelo peroxi dase, lysozyme, CD43, CD79a, or CD3. 16 Cytopatho logy is very accurate in diagnosing granulocytic sarcoma. In fact, one study found that 26 · of 27 cases were correctly diagnosed on fine-needle aspiration; the lone nondiagnostic case was subsequently diagnosed as a gra nulocy tic sarcoma on open biopsy," Cytogenetic ana lysis of the tu mor an d bone m arrow may aid in th e confirma tion of a presum pt ive diagn osis when immuno histochem ical studies produce conflicting results or when bon e marrow involveme nt in leukemia lags behind per iphera l mani festations."
Whil e th e diagn osis in our case was aided by our kn owledge of th e patient's history of chronic myelVolume 88, Number 11 www.entjournal.com · 1211 In conclusion, granulocytic sarcoma is a rare hematologic abnormality that can be effectively treated if diagnosed early and treated promptly with aggressive systemic chemotherapy. Whil e the diagnosis of this tumor has become more accurate, especially in patients who havea historyofhem atologic abnormalities,it isimportant to keep this rare entity in mind when faced with poorly differentiated neoplasms of the head and neck in order to pro vide prompt and appropriate the rap y.
